PTC Therapeutics, Inc.
Methods for treating Huntington's disease
Last updated:
Abstract:
The present description relates to compounds, forms, and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease. ##STR00001## In particular, the present description relates to substituted monocyclic heteroaryl compounds of Formula (I), forms and pharmaceutical compositions thereof and methods of using such compounds, forms, or compositions thereof for treating or ameliorating Huntington's disease.
Status:
Grant
Type:
Utility
Filling date:
11 Dec 2016
Issue date:
29 Dec 2020